company background image
600976 logo

Jianmin Pharmaceutical GroupLtd SHSE:600976 Stock Report

Last Price

CN¥48.30

Market Cap

CN¥7.3b

7D

-0.4%

1Y

-28.8%

Updated

31 Jul, 2024

Data

Company Financials +

Jianmin Pharmaceutical Group Co.,Ltd.

SHSE:600976 Stock Report

Market Cap: CN¥7.3b

Jianmin Pharmaceutical Group Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jianmin Pharmaceutical GroupLtd
Historical stock prices
Current Share PriceCN¥48.30
52 Week HighCN¥72.30
52 Week LowCN¥42.24
Beta0.58
11 Month Change-4.64%
3 Month Change-14.80%
1 Year Change-28.79%
33 Year Change2.92%
5 Year Change228.57%
Change since IPO486.52%

Recent News & Updates

Recent updates

The Market Doesn't Like What It Sees From Jianmin Pharmaceutical Group Co.,Ltd.'s (SHSE:600976) Earnings Yet As Shares Tumble 27%

Jul 12
The Market Doesn't Like What It Sees From Jianmin Pharmaceutical Group Co.,Ltd.'s (SHSE:600976) Earnings Yet As Shares Tumble 27%

We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt

Jun 30
We Think Jianmin Pharmaceutical GroupLtd (SHSE:600976) Can Stay On Top Of Its Debt

We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease

May 21
We Ran A Stock Scan For Earnings Growth And Jianmin Pharmaceutical GroupLtd (SHSE:600976) Passed With Ease

We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings

Apr 26
We Think That There Are Issues Underlying Jianmin Pharmaceutical GroupLtd's (SHSE:600976) Earnings

Shareholder Returns

600976CN PharmaceuticalsCN Market
7D-0.4%-3.1%-0.8%
1Y-28.8%-17.3%-21.8%

Return vs Industry: 600976 underperformed the CN Pharmaceuticals industry which returned -17.3% over the past year.

Return vs Market: 600976 underperformed the CN Market which returned -21.8% over the past year.

Price Volatility

Is 600976's price volatile compared to industry and market?
600976 volatility
600976 Average Weekly Movement5.7%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement5.6%
10% most volatile stocks in CN Market8.9%
10% least volatile stocks in CN Market3.8%

Stable Share Price: 600976's share price has been volatile over the past 3 months.

Volatility Over Time: 600976's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19932,497Jun Wangwww.whjm.com

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It offers medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name.

Jianmin Pharmaceutical Group Co.,Ltd. Fundamentals Summary

How do Jianmin Pharmaceutical GroupLtd's earnings and revenue compare to its market cap?
600976 fundamental statistics
Market capCN¥7.34b
Earnings (TTM)CN¥521.42m
Revenue (TTM)CN¥4.17b

14.1x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600976 income statement (TTM)
RevenueCN¥4.17b
Cost of RevenueCN¥2.33b
Gross ProfitCN¥1.84b
Other ExpensesCN¥1.32b
EarningsCN¥521.42m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 16, 2024

Earnings per share (EPS)3.43
Gross Margin44.21%
Net Profit Margin12.50%
Debt/Equity Ratio3.6%

How did 600976 perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

35%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.